vs
Side-by-side financial comparison of Natera, Inc. (NTRA) and Utz Brands, Inc. (UTZ). Click either name above to swap in a different company.
Natera, Inc. is the larger business by last-quarter revenue ($665.5M vs $361.3M, roughly 1.8× Utz Brands, Inc.). On growth, Natera, Inc. posted the faster year-over-year revenue change (39.8% vs 2.6%). Over the past eight quarters, Natera, Inc.'s revenue compounded faster (34.5% CAGR vs -0.2%).
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...
Utz Brands, Inc., more commonly known as Utz, is an American snack food company based in Hanover, Pennsylvania. The company produces a variety of potato chips, pretzels, and other snacks, with most products sold under their family of brands. Utz is also a snack supplier to warehouse clubs and merchandisers.
NTRA vs UTZ — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2027
| Metric | ||
|---|---|---|
| Revenue | $665.5M | $361.3M |
| Net Profit | $47.3M | — |
| Gross Margin | — | 25.4% |
| Operating Margin | -3.4% | 2.2% |
| Net Margin | 7.1% | — |
| Revenue YoY | 39.8% | 2.6% |
| Net Profit YoY | 187.9% | — |
| EPS (diluted) | $0.36 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $361.3M | ||
| Q4 25 | $665.5M | — | ||
| Q3 25 | $592.2M | — | ||
| Q2 25 | $546.6M | — | ||
| Q1 25 | $501.8M | — | ||
| Q4 24 | $476.1M | $341.0M | ||
| Q3 24 | $439.8M | $365.5M | ||
| Q2 24 | $413.4M | $356.2M |
| Q1 26 | — | — | ||
| Q4 25 | $47.3M | — | ||
| Q3 25 | $-87.5M | — | ||
| Q2 25 | $-100.9M | — | ||
| Q1 25 | $-66.9M | — | ||
| Q4 24 | $-53.8M | $2.3M | ||
| Q3 24 | $-31.6M | $-2.2M | ||
| Q2 24 | $-37.5M | $19.8M |
| Q1 26 | — | 25.4% | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 25.5% | ||
| Q3 24 | — | 26.9% | ||
| Q2 24 | — | 26.7% |
| Q1 26 | — | 2.2% | ||
| Q4 25 | -3.4% | — | ||
| Q3 25 | -16.5% | — | ||
| Q2 25 | -20.2% | — | ||
| Q1 25 | -15.8% | — | ||
| Q4 24 | -13.6% | 2.1% | ||
| Q3 24 | -8.9% | 5.3% | ||
| Q2 24 | -10.6% | 6.3% |
| Q1 26 | — | — | ||
| Q4 25 | 7.1% | — | ||
| Q3 25 | -14.8% | — | ||
| Q2 25 | -18.5% | — | ||
| Q1 25 | -13.3% | — | ||
| Q4 24 | -11.3% | 0.7% | ||
| Q3 24 | -7.2% | -0.6% | ||
| Q2 24 | -9.1% | 5.6% |
| Q1 26 | — | $-0.02 | ||
| Q4 25 | $0.36 | — | ||
| Q3 25 | $-0.64 | — | ||
| Q2 25 | $-0.74 | — | ||
| Q1 25 | $-0.50 | — | ||
| Q4 24 | $-0.41 | $0.04 | ||
| Q3 24 | $-0.26 | $-0.03 | ||
| Q2 24 | $-0.30 | $0.23 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $73.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.7B | $709.5M |
| Total Assets | $2.4B | $2.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $73.7M | ||
| Q4 25 | — | — | ||
| Q3 25 | $1.0M | — | ||
| Q2 25 | $16.0M | — | ||
| Q1 25 | $17.8M | — | ||
| Q4 24 | $22.7M | $56.1M | ||
| Q3 24 | $29.5M | $64.9M | ||
| Q2 24 | $90.3M | $66.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $768.6M | ||
| Q3 24 | — | $780.8M | ||
| Q2 24 | — | $797.6M |
| Q1 26 | — | $709.5M | ||
| Q4 25 | $1.7B | — | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.2B | — | ||
| Q4 24 | $1.2B | $696.9M | ||
| Q3 24 | $878.5M | $685.7M | ||
| Q2 24 | $836.5M | $686.0M |
| Q1 26 | — | $2.8B | ||
| Q4 25 | $2.4B | — | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.8B | — | ||
| Q1 25 | $1.7B | — | ||
| Q4 24 | $1.7B | $2.7B | ||
| Q3 24 | $1.6B | $2.6B | ||
| Q2 24 | $1.5B | $2.7B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.10× | ||
| Q3 24 | — | 1.14× | ||
| Q2 24 | — | 1.16× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $73.9M | $-12.2M |
| Free Cash FlowOCF − Capex | $37.8M | — |
| FCF MarginFCF / Revenue | 5.7% | — |
| Capex IntensityCapex / Revenue | 5.4% | 3.8% |
| Cash ConversionOCF / Net Profit | 1.56× | — |
| TTM Free Cash FlowTrailing 4 quarters | $109.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $-12.2M | ||
| Q4 25 | $73.9M | — | ||
| Q3 25 | $59.4M | — | ||
| Q2 25 | $37.6M | — | ||
| Q1 25 | $44.5M | — | ||
| Q4 24 | $52.9M | $54.2M | ||
| Q3 24 | $51.8M | $52.2M | ||
| Q2 24 | $4.0M | $8.9M |
| Q1 26 | — | — | ||
| Q4 25 | $37.8M | — | ||
| Q3 25 | $37.0M | — | ||
| Q2 25 | $11.7M | — | ||
| Q1 25 | $22.6M | — | ||
| Q4 24 | $34.8M | $16.5M | ||
| Q3 24 | $35.5M | $29.1M | ||
| Q2 24 | $-7.7M | $-15.3M |
| Q1 26 | — | — | ||
| Q4 25 | 5.7% | — | ||
| Q3 25 | 6.2% | — | ||
| Q2 25 | 2.1% | — | ||
| Q1 25 | 4.5% | — | ||
| Q4 24 | 7.3% | 4.8% | ||
| Q3 24 | 8.1% | 8.0% | ||
| Q2 24 | -1.9% | -4.3% |
| Q1 26 | — | 3.8% | ||
| Q4 25 | 5.4% | — | ||
| Q3 25 | 3.8% | — | ||
| Q2 25 | 4.7% | — | ||
| Q1 25 | 4.3% | — | ||
| Q4 24 | 3.8% | 11.1% | ||
| Q3 24 | 3.7% | 6.3% | ||
| Q2 24 | 2.8% | 6.8% |
| Q1 26 | — | — | ||
| Q4 25 | 1.56× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 23.67× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.45× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.